Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Something is going on

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon May 03, 2024 10:02am

95 Views

Post# 36021451

RE:RE:Something is going on

" The timing coincides with Sirona reaching out to the financial market after closing the private placement that did not meet the expectations. "

The two are unrelated. The PP was for short-term spending money, the search for a partner for Sirona Labs is for the rollout of the GlycoProteMim products. Rumors are that the latter is close.

<< Previous

Bullboard Posts

Next >>

Junior helium stock to benefit from new legislation in U.S.